Loading...
OTCM
MLLNF
Market cap191mUSD
Sep 18, Last price  
6.40USD
Name

Malin Corporation PLC

Chart & Performance

D1W1MN
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-16.17%
Rev. gr., 5y
8.79%
Revenues
0k
22,900,00042,100,00041,900,00038,000,00034,900,00041,000,0000000
Net income
0k
-44,900,000-83,500,000-98,800,000-46,300,000-5,200,00087,700,000-500,00012,900,00000
CFO
-1m
L-59.38%
-17,000,000-22,400,000-27,200,000-13,400,000-4,100,000-3,000,000-4,600,000-7,200,000-3,200,000-1,300,000
Earnings
Aug 25, 2025

Profile

Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States. It offers life-saving cell and gene therapies for patients with high unmet medical need; medicines to address unmet needs in cancer, infection, and autoimmune diseases; and treatment of recurrent vulvovaginal candidiasis, an unmet need in women's health and onychomycosis or fungal nail infection. The company also provides drugs for protein misfolding diseases; and platform to distinguish disease-driving bacteria from the intestinal microbiota, as well as UV-light disinfection technology solutions. In addition, it provides company secretarial services. Malin Corporation plc was incorporated in 2014 and is headquartered in Dublin, Ireland.
URL
http://malinplc.com/
IPO date
Mar 25, 2015
Employees
Domiciled in
IE
Incorporated in
IE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
2,400
3,900
200
Unusual Expense (Income)
NOPBT
(2,400)
(3,900)
(200)
NOPBT Margin
Operating Taxes
(600)
Tax Rate
NOPAT
(2,400)
(3,900)
400
Net income
12,900
-2,680.00%
Dividends
Dividend yield
Proceeds from repurchase of equity
(140,800)
BB yield
140.31%
Debt
Debt current
100
100
Long-term debt
100
100
Deferred revenue
Other long-term liabilities
6,100
Net debt
(62,100)
(110,300)
(173,808)
Cash flow
Cash from operating activities
(1,300)
(3,200)
(7,200)
CAPEX
Cash from investing activities
34,100
400
149,100
Cash from financing activities
(100)
(141,700)
(200)
FCF
(2,300)
(3,900)
400
Balance
Cash
62,100
35,700
173,900
Long term investments
74,800
108
Excess cash
62,100
110,500
174,008
Stockholders' equity
247,900
118,200
257,000
Invested Capital
131,100
5,200
109,192
ROIC
0.27%
ROCE
EV
Common stock shares outstanding
19,000
22,300
34,300
Price
8.60
91.11%
4.50
-38.02%
7.26
8.36%
Market cap
163,400
62.83%
100,350
-59.70%
249,018
-16.67%
EV
101,300
(9,950)
75,210
EBITDA
(2,300)
(3,700)
100
EV/EBITDA
2.69
752.10
Interest
200
200
Interest/NOPBT